Literature DB >> 11124815

Risk factors for primary biliary cirrhosis in a cohort of patients from the united states.

A Parikh-Patel1, E B Gold, H Worman, K E Krivy, M E Gershwin.   

Abstract

Although the etiology of primary biliary cirrhosis (PBC) remains unknown, environmental factors may act to trigger the disease in genetically susceptible hosts. To assess specific risk factors, we conducted a survey using standardized NHANES questions to 241 PBC patients in the United States, 261 of their siblings, and 141 friends without PBC. The overall response rate was 199 of 241 (83%) among PBC cases, 171 of 261 (67%) among siblings, and 141 of 225 (62. 7%) among friend controls. The female-to-male ratio among cases in this sample was approximately 10:1; the mean age was 53 years, and 97% were Caucasian. Other autoimmune diseases reported most frequently by PBC cases included Sjogren's syndrome (17.4%) and Raynaud's syndrome (12.5%). Approximately 6% of cases reported at least one family member with PBC. Adjusted odds ratios (OR) were elevated for cases compared with friends for other autoimmune diseases (OR = 4.92, 95% confidence interval [CI] = 2.38, 10.18), smoking (OR = 2.04, 95% CI = 1.10, 3.78), tonsillectomy (OR = 1.86, 95% CI = 1.02, 3.39), and vaginal or urinary tract infection (UTI) in females only (OR = 2.12, 95% CI = 1.10, 4.07). Similarly elevated ORs were observed for these risk factors when cases were compared with their siblings. The higher rate of UTI among cases is particularly interesting in light of previous data, and raises the possibility of an infectious etiology for PBC and of molecular mimicry as an etiologic mechanism. The significance of smoking in the multivariate models supports the findings of previous studies and raises the issue of the influence of smoking on a Th1 response.

Entities:  

Mesh:

Year:  2001        PMID: 11124815     DOI: 10.1053/jhep.2001.21165

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  61 in total

1.  Primary biliary cirrhosis after aortoiliac reconstruction surgery using a Y-graft.

Authors:  Tomoko Inoue; Katsuya Shiraki; Hiroyuki Fuke; Yutaka Yamanaka; Kazumi Miyashita; Keiichi Ito; Masahiro Suzuki; Kazushi Sugimoto; Kazumoto Murata; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

2.  Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation.

Authors:  Alina M Allen; Julie K Heimbach; Joseph J Larson; Kristin C Mara; W Ray Kim; Patrick S Kamath; Terry M Therneau
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

3.  Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice.

Authors:  J J Wang; G-X Yang; W C Zhang; L Lu; K Tsuneyama; M Kronenberg; J L Véla; M Lopez-Hoyos; X-S He; W M Ridgway; P S C Leung; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

4.  Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.

Authors:  Jennifer Guy; Marion G Peters
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-10

Review 5.  Gender-based disparities in access to and outcomes of liver transplantation.

Authors:  Omobonike O Oloruntoba; Cynthia A Moylan
Journal:  World J Hepatol       Date:  2015-03-27

Review 6.  Pathogenesis of primary biliary cirrhosis: a unifying model.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 7.  Pathogen infections and primary biliary cholangitis.

Authors:  A Tanaka; P S C Leung; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2018-09-17       Impact factor: 4.330

8.  Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Authors:  Angela C Cheung; Nicholas F LaRusso; Gregory J Gores; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2017-05-31       Impact factor: 6.115

9.  Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis.

Authors:  K Harada; S Shimoda; Y Sato; K Isse; H Ikeda; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.